BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET

Buprenorphine and Naloxone
$0.6681per EA
DEA Schedule CIII

Strength

8; 2 mg/1; mg/1

NDC

62175045832

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Last Updated

4/22/2026

Active Ingredients

BUPRENORPHINE; NALOXONE

Approval Type

Generic (ANDA)

FDA Application

ANDA205022

On Market Since

9/19/2016

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

+1.0%

3M

-4.5%

6M

-5.0%

1Y

-8.2%

3Y

-34.7%

5Y

-45.6%

All

-66.9%